Showing results (651-660 of 5,044) with videos related to
Sort By:
Pageof 505
Multiple Sclerosis and Related Disorders|April 18, 2021
Failure of IVIG in steroid-responsive autoimmune glial fibrillary acidic protein astrocytopathy: A case reportElena S Heide, Amit Chaudhari, Ateena Pirverdian, et al.Multiple Sclerosis and Related Disorders|April 30, 2023
Vascular disease risk factors in multiple sclerosis: Effect on metabolism and brain volumesManoj K Sammi, Allison Fryman, Eric Baker, et al.Multiple Sclerosis and Related Disorders|September 22, 2022
COVID-19 severity among patients with multiple sclerosis treated with cladribine: A systematic review and meta-analysisAngela Albanese, Maria Pia Sormani, Giovanni Gattorno, et al.Multiple Sclerosis and Related Disorders|September 23, 2022
Economic evaluation of cladribine tablets in high disease activity (HDA) relapsing multiple sclerosis (RMS) patients in LebanonMirna Matni, Bassem Yamout, Salam Koussa, et al.Multiple Sclerosis and Related Disorders|September 30, 2022
The impact of sociodemographic characteristics on diagnosis and access to disease-modifying treatment for patients with multiple sclerosis in MoroccoRachid Lotfi, Fatiha Chigr, Mohamed NajimiMultiple Sclerosis and Related Disorders|September 20, 2022
Clinical onset of CNS demyelinating disease after COVID-19 vaccination: denovo disease?J A Gernert, H Zimmermann, E Oswald, et al.Multiple Sclerosis and Related Disorders|October 24, 2022
Amyloid-Eszett (Aß), a false positive of amyloid-beta (Aβ)Jaime A Teixeira da SilvaMultiple Sclerosis and Related Disorders|October 24, 2022
A pilot study comparing myelin measurements from myelin water imaging and 11C-PIB PET in multiple sclerosisIrene M Vavasour, Nasim Vafai, Philippe Beauchemin, et al.Multiple Sclerosis and Related Disorders|October 26, 2022
The impact of PM2.5, PM10 and NO2 on Covid-19 severity in a sample of patients with multiple sclerosis: A case-control studyMarta Ponzano, Irene Schiavetti, Roberto Bergamaschi, et al.Multiple Sclerosis and Related Disorders|October 25, 2022
Impact of resilience, social support, and personality traits in patients with neuroinflammatory diseases during the COVID-19 pandemicDejan Jakimovski, Katelyn S Kavak, Erin E Longbrake, et al.Pageof 505